Additionally, more investigations are needed to elucidate how ox-LDL accumulation decreases SCGN expression and whether the SCGN-regulated NLRP3/Caspase-1 pathway is impaired in patients with hypercholesterolemia. This evidence concerns the gene NLRP3 and familial hypercholesterolemia.